We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sullivan & Cromwell Reps Amgen In $1B BioVex Deal

Law360 (January 25, 2011, 2:11 PM EST) -- Amgen Inc. has agreed to pay up to $1 billion to acquire Woburn, Mass.-based biotechnology company BioVex Group Inc., the maker of an experimental cancer vaccine.

In an announcement Monday, Thousand...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.